De Groote J
Afdeling Hepatologie, Katholieke Universiteit Leuven, UZ Gasthuisberg, Belgium.
Acta Gastroenterol Belg. 1991 Jan-Feb;54(1):19-26.
In the mitochondria nine antigens and their corresponding antibodies are already known. They can be subdivided in three groups. The first one (M2-M4-M6-M8) appears during the evolution of primary biliary cirrhosis. The antibody against M2 is practically pathognomic for this disease. The M9-antibody is found in PBC with a slow and favourable evolution. The antibodies against M4-M8 are signs of a worse prognosis and a more rapid evolution into terminal cirrhosis. The second group is connected with infections and collagen diseases. The M1-antibody is directed against cardiolipin and diagnostic for syphilis. The M5-antibody appears in definite collagenoses. The M7-antibody is found in certain forms of acute and chronic cardiomyopathy. The third group of antibodies is induced by drugs: the anti-M3 by Venocuran containing a.o. phenopyrazone and the anti-M6 by Iproniazid. The role of the antigens and their antibodies concerning the aetiology and pathogenesis of the relevant diseases, especially primary biliary cirrhosis, is not known.
在线粒体中,已知有九种抗原及其相应抗体。它们可分为三组。第一组(M2 - M4 - M6 - M8)出现在原发性胆汁性肝硬化的病程中。抗M2抗体实际上是这种疾病的特征性抗体。M9抗体见于病情进展缓慢且预后良好的原发性胆汁性肝硬化患者。抗M4 - M8抗体提示预后较差,且更易迅速发展为终末期肝硬化。第二组与感染和胶原病有关。M1抗体针对心磷脂,是梅毒的诊断依据。M5抗体出现在某些胶原病中。M7抗体见于某些急性和慢性心肌病。第三组抗体由药物诱导产生:含非那宗等成分的维诺库兰可诱导产生抗M3抗体,异烟酰异丙肼可诱导产生抗M6抗体。这些抗原及其抗体在相关疾病,尤其是原发性胆汁性肝硬化的病因和发病机制中的作用尚不清楚。